-
Experimental Bacteria Treatment Could Disrupt CF-related B. cepacia Biofilms
An experimental large sugar molecule called poly (acetyl, arginyl) glucosamine, or PAAG, was able to disrupt treatment-resistant biofilms formed by Burkholderia cepacia complex bacteria extracted from patients with cystic fibrosis (CF), according to a study.
Click here to read an overview of the study and its findings.
What do you think of this news?
Sorry, there were no replies found.
Log in to reply.